Table 2. Comparison of clinico-pathological features of the induction therapy group and the direct surgery group (not including stage IV diseases).
| Variables | IT (n=55) | DS (n=499) | P value |
|---|---|---|---|
| Gender | 0.941 | ||
| Male | 34 (61.8%) | 311 (62.3%) | |
| Female | 21 (38.2%) | 188 (37.7%) | |
| Age (yr, mean ± SD) | 45.3±14.7 | 51.6±13 | 0.135 |
| Tumor size (cm, mean ± SD) | 7.96±2.7 | 7.92±3.2 | 0.224 |
| Preoperative MG | 0.000 | ||
| No | 50 (90.9%) | 379 (76%) | |
| Yes | 5 (9.1%) | 120 (24%) | |
| WHO histology | 0.022 | ||
| Thymoma | 26 (47.3%) | 300 (60.1%) | |
| C + NETT | 29 (52.7%) | 199 (39.9%) | |
| Resection state | 0.63 | ||
| R0 | 42 (76.4%) | 366 (73.3%) | |
| R1 + R2 | 13 (23.6%) | 133 (26.7%) |